Kashiv signs deal with CRISTÁLIA for Xolair biosimilar in LATAM
CRISTÁLIA will manage the licensing, distribution and commercialisation efforts of the biosimilar in the region.
Drug Development
GTCR to acquire generic drug maker Zentiva
Kriya gains $320m in Series D for gene therapy development
Sanofi’s Tzield gains approval in China for T1D management
Kytopen and BlueWhale Bio partner for cell therapy innovation
Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS
Servier to acquire potential Fragile X syndrome treatment from Kaerus
Epigenic raises $60m for epigenetic treatment development
